# A Multiple Dose Study of MK-3614 (MK-3614-002)

> **NCT01033643** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 30 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** MK-3614
- **DRUG:** Placebo for MK-3614

## Key facts

- **NCT ID:** NCT01033643
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-27
- **Primary completion:** 2009-12-09
- **Final completion:** 2009-12-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01033643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01033643, "A Multiple Dose Study of MK-3614 (MK-3614-002)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01033643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*